Biggest News Aggregation in the World
📰 John Cunningham News

Page 3 - John Cunningham News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from John Cunningham. Real-time updates on events, politics, business and more.

Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its oncology and hematology portfolio at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
United States South Korea Pushkar Mutha Mariat Bourlon Tycel Jovelle Phillips Tony Mok

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Bristol Myers Squibb's CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma

95.7% of patients responded to Breyanzi in the TRANSCEND FL trial Breyanzi provided sustained clinical benefit with median duration of response not reached and the majority of responders in...
United Kingdom Hemophagocytic Lymphohistiocytosis Meghan Gutierrez Bryan Campbell Bristol Myers Squibb John Cunningham

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science